BA

Bambusa Therapeutics

Austin, US · 6 known investors

bambusatx.com ↗

Bambusa Therapeutics develops bispecific antibodies for immunological and inflammatory (I&I) disorders, using antibody engineering to target multiple I&I indications. The clinical-stage biotech company serves patients across a range of I&I diseases.

Investors · 6

IN

INCE Capital✓ verifiedShanghai

BI

Biotechnology Value Fund✓ verifiedSan Francisco

JA

Janus Henderson Investors✓ verifiedNew York

RA

RA Capital✓ verifiedBoston

RE

REDMILE✓ verifiedSan Francisco

SA

Salvia✓ verifiedHolzkirchen